论文部分内容阅读
目的:探讨对支气管哮喘进行临床药物治疗的效果。方法:对我院68例支气管哮喘患者临床资料进行回顾性分析,将所有的患者随机分为两组,观察组给予布地奈德联合特布他林雾化治疗,对照组给予常规治疗。观察两组患者的各项临床症状和体征变化。结果:观察组中临床控制25例,好转8例,1例无效,总有效率为97.1%;对照组中临床控制12例,好转13例,无效9例,总有效率为73.5%。两者比较有显著性的统计学差异(P<0.05)。结论:布地奈德联合特布他林雾化吸入治疗支气管哮喘取得满意的治疗效果,无任何严重的毒副作用,值得在临床中推广应用。
Objective: To investigate the effect of clinical medication on bronchial asthma. Methods: The clinical data of 68 patients with bronchial asthma in our hospital were retrospectively analyzed. All the patients were randomly divided into two groups. The observation group received budesonide combined with terbutaline nebulization and the control group received conventional treatment. The clinical symptoms and signs of two groups were observed. Results: In the observation group, 25 cases were controlled and 8 cases were improved. One case was ineffective and the total effective rate was 97.1%. In the control group, 12 cases were clinically controlled, 13 cases improved, 9 cases ineffective, and the total effective rate was 73.5%. There was a significant statistical difference between the two (P <0.05). Conclusion: Budesonide combined with Terbutaline nebulized bronchial asthma achieved satisfactory therapeutic effect, without any serious side effects, which is worth popularizing in clinic.